Drug Name,Drug Bank,MOA,Experiments,Methods,Parameter,Mean,Unit
Remdesivir,https://www.drugbank.ca/drugs/DB14761,Nucleobindin-1 (NUCB1) Inhibitors,"Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO",Viral replication assay,IC-50,1.00E-08,M
Emetine,https://www.drugbank.ca/drugs/DB13393,Platelet-Derived Growth Factor (PDGF) Inhibitors;Signal Transduction Modulators;Angiogenesis Inhibitors,"Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO",Cytopathicity assay,IC-50,1.50E-07,M
Nafamostat mesilate,https://www.drugbank.ca/drugs/DB12598,Tryptase Inhibitors,"Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO",Vero cells (TMPRSS2-expressing) transfected with MERS,IC-50,1.00E-09,M
Alisporivir,https://www.drugbank.ca/drugs/DB12139,P-Glycoprotein (MDR-1; ABCB1) Inhibitors;Cyclophilin Inhibitors,"Coronavirus acute respiratory syndrome remission/reduction, IN VITRO",RNA assay,IC-50,8.00E-07,M
Lycorine,https://www.drugbank.ca/drugs/DB11231,,"Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO",Dye assay,IC-50,1.57E-08,M
Niclosamide,https://www.drugbank.ca/drugs/DB06803,Cytochrome P450 CYP1A2 Inhibitors;Quorum Sensing (Pseudomonas aeruginosa) Inhibitors;Neuropeptide Y4 (NPY Y4) Receptor Positive Allosteric Modulators;Autophagy Inducers;Wnt Signaling Inhibitors,"Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO",Cytopathicity assay,IC-50,1.00E-07,M
Rupintrivir,https://www.drugbank.ca/drugs/DB05102,HRV 3C Protease Inhibitors,"Coronavirus acute respiratory syndrome remission/reduction, IN VITRO",Viral replication assay,IC-50,3.00E-07,M
Geldanamycin,https://www.drugbank.ca/drugs/DB02424,Signal Transduction Modulators;Heat Shock Protein 90 (Hsp90) Inhibitors,"Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO",,IC-50,9.10E-07,M
Sinefungin,https://www.drugbank.ca/drugs/DB01910,Coactivator Associated Arginine Methyltransferase 1 (CARM1; PRMT4) Inhibitors;Histone-Lysine N-Methyltransferase SETD7 (SET7/9) Inhibitors;Protein-L-Isoaspartate(D-Aspartate) O-Methyltransferase (PCMT1; PIMT) Inhibitors;Epigenetic Modifier Modulators,"Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO",,IC-50,3.83E-07,M
Mycophenolic acid sodium salt,https://www.drugbank.ca/drugs/DB01024,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,"Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO",Cytopathicity assay,IC-50,1.70E-07,M
Mycophenolate mofetil,https://www.drugbank.ca/drugs/DB00688,Hydroxycarboxylic Acid Receptor 2 (HCAR2; NIACR1; GPR109A) Agonists;Signal Transduction Modulators;Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,"Coronavirus acute respiratory syndrome remission/reduction, IN VITRO",Viral replication assay,IC-50,2.30E-07,M
Chloroquine,https://www.drugbank.ca/drugs/DB00608,,"Coronavirus acute respiratory syndrome remission/reduction, IN VITRO",,IC-50,8.00E-10,M
Gemcitabine hydrochloride,https://www.drugbank.ca/drugs/DB00441,Ribonucleoside-Diphosphate Reductase Inhibitors;Pyrimidine Antagonists,"Coronavirus acute respiratory syndrome remission/reduction, IN VITRO",Cytopathicity assay,IC-50,4.40E-07,M
Promazine,https://www.drugbank.ca/drugs/DB00420,Signal Transduction Modulators;Dopamine Receptor Antagonists,"Coronavirus acute respiratory syndrome remission/reduction, IN VITRO",Cytopathicity assay,MIC,1.00E-07,M
Azithromycin,https://www.drugbank.ca/drugs/DB00207,Nonsense Mutation Suppressors;50S Ribosomal Protein Inhibitors,"Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO",Luciferine/luciferase assay,IC-50,1.00E-07,M
[N-MeIle4]-cyclosporin,https://www.drugbank.ca/drugs/DB00091,Cyclophilin Inhibitors;Mitochondrial Permeability Transition (MPT) Inhibitors,"Coronavirus acute respiratory syndrome remission/reduction, IN VITRO",RNA assay,IC-50,8.00E-07,M
Ciclosporin,https://www.drugbank.ca/drugs/DB00091,Cyclophilin D Inhibitors;Signal Transduction Modulators;Serine/Threonine-Protein Phosphatase 2B (PPP3CC; PP2Bgamma; Calcineurin) Inhibitors;INS Expression Inhibitors,"Coronavirus acute respiratory syndrome remission/reduction, IN VITRO",RNA assay,IC-50,9.00E-07,M